SCHEMBL9114832

SCHEMBL9114832

C[CH]c1cnnc2ccccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 3/20 0.44
TGFBR1 P36897 1/20 0.37
CYP1A2 P05177 4/20 0.36
CYP2C19 P33261 3/20 0.36
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 4/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
LMNA P02545 3/20 0.33
NPC1 O15118 3/20 0.33
TP53 P04637 2/20 0.33
HTT P42858 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
MAPT P10636 2/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2009244 0.80 GPR3 (0.44) GPR3TGFBR1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL13134221 0.80 GPR3 (0.44) GPR3TGFBR1CYP1A2CYP2C19ALDH1A1
SCHEMBL2491044 0.76 MAPT (0.44) GPR3ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL10738298 0.76 HPGD (0.42) GPR3TGFBR1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL2491042 0.76 MAPT (0.44) GPR3ALDH1A1KDM4ESMN1; SMN2LMNA
SCHEMBL10738301 0.76 HPGD (0.42) GPR3TGFBR1ALDH1A1KDM4ESMN1; SMN2
SCHEMBL10843177 0.75 NPC1 (0.37) GPR3TGFBR1CYP1A2CYP2C19ALDH1A1
Hydrochloric Acid SCHEMBL10842837 0.74 HPGD (0.41) GPR3TGFBR1CYP1A2CYP2C19ALDH1A1
SCHEMBL9111565 0.74 GPR3 (0.39) GPR3TGFBR1CYP1A2CYP2C19ALDH1A1
SCHEMBL436407 0.72 GPR3 (0.50) GPR3TGFBR1CYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1114834-A antidiabetic agent OTSUKA PHARMA CO LTD (JP) 1996-01-10 CN disclosed
US-5459142-A Autoimmune disease, atherosclerosis, antiischemic agents and nephritis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-10-17 US disclosed
EP-0670831-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-09-13 EP disclosed
WO-1995009159-A1 QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) 1995-04-06 WO disclosed